Navigating the Cancer Landscape Using Innovative Pharmacoepidemiologic Methods

Moderator(s)

• OO

  Oluwadamilola Onasanya, MD, MPH, PhD Candidate

  PhD Candidate/Senior Researcher, Safety and Epidemiology
  University of Maryland, Baltimore/Carelon Research
  Baltimore, United States
• 

  Blanaid Hicks, PhD

  Senior Lecturer
  Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland, United Kingdom

Presentations:

• 1:00 PM – 1:15 PM CEST

  Immune-Related Adverse Events of Anti-PD-(L)1 Immunotherapy With and Without Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Evidence Study
  

  Presenting Author: Ping Shao, M.B.B.S, MS – Regeneron

  Co-Author: Alexi N. Archambault, PhD, MPH – Regeneron

  Co-Author: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals

  Co-Author: Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron

  Co-Author: Julius Asubonteng, PhD – Regeneron

  Co-Author: Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc.

  Co-Author: Asha B. Pillai, MD – Regeneron
• 1:15 PM – 1:30 PM CEST

  Developing a de-novo mortality model for relapsed and refractory multiple myeloma: emulation of subjective life expectancy criteria from a clinical trial in real-world data
  

  Co-Author: Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals

  Co-Author: Paul Spin – Eversana

  Co-Author: Di Wang – Eversana

  Co-Author: Qiufei Ma – Regeneron Pharmaceuticals

  Co-Author: Glenn S. Kroog – Regeneron Pharmaceuticals

  Presenting Author: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals
• 1:30 PM – 1:45 PM CEST

  The Comparative Risk of Urinary Tract Infections with Degarelix and Gonadotropin-Releasing Hormone Agonists among Patients Diagnosed with Prostate Cancer: A Population-Based Cohort Study
  

  Presenting Author: Farzin Khosrow-Khavar, PhD – Rutgers University

  Co-Author: Elisa Bandera, MD, PhD – Rutgers Cancer Institute of New Jersey

  Co-Author: Chintan Dave, PharmD, PhD – Rutgers University
• 1:45 PM – 2:00 PM CEST

  Comparative effectiveness and cardiovascular safety of enzalutamide versus abiraterone amongst older U.S. men diagnosed with metastatic castration-resistant prostate cancer
  

  Presenting Author: Charles E. Gaber, PhD, MPH (he/him/his) – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA

  Co-Author: Ebere Okpara, BPharm – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA

  Co-Author: Abdullah I. Abdelaziz, BPharm, MS – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA

  Co-Author: Jyotirmoy Sarker, MPharm, MBA, MBiotech – University of Illinois Chicago, Department of Pharmacy Systems, Outcomes and Policy

  Co-Author: Kent A. Hanson, PharmD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA

  Co-Author: Lubna Hassan, PharmD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA

  Co-Author: Fang-Ju Lin, PhD, MS – 1 Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA

  Co-Author: Todd A. Lee, PharmD, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago

  Co-Author: Natalie Reizine, MD – Division of Hematology & Oncology, Department of Medicine, University of Illinois-Chicago College of Medicine, Chicago, IL, USA
• 2:00 PM – 2:15 PM CEST

  Incidence and Survival of Pregnancy Associated Breast Cancer: A Contribution from the IMI ConcePTION Project Piloted in Finland and Norway
  

  Presenting Author: Maarit K. Leinonen, MD, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  Co-Author: Visa Martikainen – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland

  Co-Author: Cori Campbell, DPhil – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands

  Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  Co-Author: Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA

  Co-Author: Joan K. Morris – Population Health Research Institute, St George’s, University of London, UK

  Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway

  Co-Author: Mika Gissler, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
• 2:15 PM – 2:30 PM CEST

  Hypothetical target trial to compare the effectiveness of atezolizumab, pembrolizumab and nivolumab in second line treatment of advanced non-small cell lung cancer
  

  Presenting Author: Euloge Clovis Kenne Pagui, PhD – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Norway

  Co-Author: Simon Boge Brant – NordicRWE AS, Oslo, Norway

  Co-Author: Kristian Svendsen, PhD – NordicRWE AS, Oslo, Norway

  Co-Author: Arnoldo Frigessi – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo

  Co-Author: Åslaug Helland – Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo

  Co-Author: Steinar Ø Thoresen, MD PhD Professor emeritus – NordicRWE AS, Oslo, Norway

  Co-Author: Christian Jonasson – Norwegian University of Science and Technology